{"title": "Ophthalmologic evidence against the interpersonal transmission of 2019 novel coronavirus through conjunctiva", "doi": "10.1101/2020.02.11.20021956", "citation_id": "2020.02.11.20021956v1", "date": "2020-02-12", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.11.20021956", "abstract": "<p>Background: The emerging 2019 novel coronavirus (2019\u2212nCoV) has pushed several countries into state of emergency all over the world. The possible transmission of 2019\u2212nCoV by conjunctiva is controversial and has substantial public health implications.\nMethods: A retrospective cohort study was initiated to investigate the possible transmission of 2019\u2212nCoV through aerosol contact with conjunctiva. We enrolled 67 cases of confirmed or suspected cases of novel coronavirus pneumonia (NCP) during 17\u221228 Jan 2020. Nasopharyngeal and conjunctival swabs were collected for real time RT-PCR analysis to detect 2019\u2212nCoV.\nResults: 63 patients were identified as laboratory\u2212confirmed NCP and the remaining four were suspected NCP. Conjunctival swab samples from one NCP patient yielded positive PCR results and two NCP patients yielded probable positive PCR results. None of the three patients had ocular symptoms. The only one NCP patient with conjunctivitis as the first symptom had negative conjunctival sac 2019\u2212nCoV test. Conjunctival swab samples from the four suspected cases of NCIP were negative.\nConclusion: 2019\u2212nCoV can be detected in the conjunctival sac of patients with NCP. Through clinical analysis, viral transmission via the conjunctival route was not supported by the data. Good clinical protection can effectively cut off the transmission path.</p>", "twitter_description": "Background: The emerging 2019 novel coronavirus (2019\u2212nCoV) has pushed several countries into state of emergency all over the world. The possible transmission of 2019\u2212nCoV by conjunctiva is controversial and has substantial public health implications. Methods: A retrospective cohort study was initiated to investigate the possible transmission of 2019\u2212nCoV through aerosol contact with conjunctiva. We enrolled 67 cases of confirmed or suspected cases of novel coronavirus pneumonia (NCP) during 17\u221228 Jan 2020. Nasopharyngeal and conjunctival swabs were collected for real time RT-PCR analysis to detect 2019\u2212nCoV. Results: 63 patients were identified as laboratory\u2212confirmed NCP and the remaining four were suspected NCP. Conjunctival swab samples from one NCP patient yielded positive PCR results and two NCP patients yielded probable positive PCR results. None of the three patients had ocular symptoms. The only one NCP patient with conjunctivitis as the first symptom had negative conjunctival sac 2019\u2212nCoV test. Conjunctival swab samples from the four suspected cases of NCIP were negative. Conclusion: 2019\u2212nCoV can be detected in the conjunctival sac of patients with NCP. Through clinical analysis, viral transmission via the conjunctival route was not supported by the data. Good clinical protection can effectively cut off the transmission path.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nall data generated or used during this study are available from the corresponding author by request.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.11.20021956v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.11.20021956v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.11.20021956v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/12/2020.02.11.20021956.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.11.20021956v1", "access_rights": "restricted", "authors": ["Yunyun Zhou", "Yuyang Zeng", "Yongqing Tong", "ChangZheng Chen"]}